OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
31 hedge funds and large institutions have $13.8M invested in OncoSec Medical Incorporated in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 14 closing their positions.
158% more call options, than puts
Call options by funds: $191K | Put options by funds: $74K
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
11% less funds holding
Funds holding: 35 → 31 (-4)
28% less capital invested
Capital invested by funds: $19.2M → $13.8M (-$5.34M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$728K |
| 2 |
SM
Salzhauer Michael
|
+$530K |
| 3 |
Two Sigma Advisers
New York
|
+$467K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$334K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$180K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$1.89M |
| 2 |
Renaissance Technologies
New York
|
-$662K |
| 3 |
Two Sigma Investments
New York
|
-$525K |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$449K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$354K |
ONCS Hedge Fund Activity: Q3 2021 in Review
31 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2021, worth a combined $13.8M — down 28% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ONCS and 10 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Nexpoint Asset Management, opening a new position worth an estimated $728K. The largest seller was Holocene Advisors, exiting entirely with an estimated $1.89M sold.
- 31 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2021, down from 35 in Q2 2021.
- Funds reported $13.8M of OncoSec Medical Incorporated stock for Q3 2021, down 28% quarter-over-quarter.
- 10 funds opened new OncoSec Medical Incorporated positions in Q3 2021 and 14 closed out, a net change of -4 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2021 was Nexpoint Asset Management, an estimated $728K added.
- The largest OncoSec Medical Incorporated seller in Q3 2021 was Holocene Advisors, an estimated $1.89M sold.
Based on aggregated 13F filings for Q3 2021.